Ayla Hale
Medical · Corona, CANPI 1003457474
Payments from drug & device makers
Across 125 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$337
- Biohaven Pharmaceuticals, Inc.$312
- AstraZeneca$265
- GSK$216
- Teva Pharmaceuticals USA, Inc.$178
- Sumitomo Pharma America, Inc.$155
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,567100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $337 |
| Biohaven Pharmaceuticals, Inc. | 12 | $312 |
| AstraZeneca | 12 | $265 |
| GSK | 8 | $216 |
| Teva Pharmaceuticals USA, Inc. | 9 | $178 |
| Sumitomo Pharma America, Inc. | 11 | $155 |
| Novo Nordisk | 8 | $155 |
| Lilly USA, LLC | 8 | $135 |
| Astellas Pharma US Inc | 6 | $129 |
| Amgen | 6 | $113 |
| Pfizer | 5 | $100 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $73 |
| Boehringer Ingelheim | 3 | $65 |
| Merck | 3 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $40 |
| Novartis | 2 | $38 |
| Bayer | 1 | $36 |
| Si-bone, Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Agile Therapeutics, Inc. | 1 | $22 |
| Edwards Lifesciences | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$125
How this compares
$2,567 in reported general payments places this provider in the 75th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 12 | $12,753 |
| JanuviaSitagliptin Phosphate | 11 | $11,076 |
| MyrbetriqMirabegron | 11 | $6,535 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $5,773 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 17 | $901 |
| Atorvastatin Calcium | 83 | $738 |
| Levothyroxine Sodium | 60 | $664 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $654 |
| Gabapentin | 48 | $572 |
| Metoprolol Succinate | 16 | $321 |
| Omeprazole | 22 | $299 |
| Diclofenac Sodium | 17 | $291 |
| Rosuvastatin Calcium | 13 | $273 |
| Amlodipine Besylate | 42 | $205 |
| Pantoprazole Sodium | 11 | $190 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $135 | $12,75312 claims |
| MerckJanuvia | $45 | $11,07611 claims |
| Astellas Pharma US IncMyrbetriq | $129 | $6,53511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 medical providers in California.
Other medical in Corona
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.